• Español
Logotipo BioKeralty
  • Home
  • BioKeralty
  • Areas and lines of research
  • Projects
  • Resources
  • Contact
/ Resources / Featured news / IN-ARMOR Project Gains International Spotlight in Iceland for its Revolutionary Approach to Antimicrobial Resistance

IN-ARMOR Project Gains International Spotlight in Iceland for its Revolutionary Approach to Antimicrobial Resistance

May 12 2026
YIDOSA Websites 0 Comments

IN-ARMOR Project Gains International Spotlight in Iceland for its Revolutionary Approach to Antimicrobial Resistance

Biokeralty Research Institute continues to strengthen its role as a bridge between the European Research Area (ERA) and global clinical practice through its participation in high-impact international projects. Recently, the IN-ARMOR project, an initiative aimed at transforming how we fight infections, has received significant media coverage in Iceland, appearing in major national outlets such as the daily newspaper Morgunblaðið and the broadcaster RÚV.

A Disruptive Strategy Against “Superbugs"

The media attention focuses on IN-ARMOR’s innovative approach to Antimicrobial Resistance (AMR), which the World Health Organization (WHO) has designated as one of the top ten global public health threats. As traditional antibiotics lose their effectiveness, Biokeralty and its partners are working on Host-Directed Therapy (HDT).

Unlike conventional treatments that attack pathogens directly, this technology seeks to strengthen the body’s own innate immune defenses. By inducing host defense peptides (AMPs) and reinforcing epithelial barriers, the therapy helps the human body stop infections on its own, preventing bacteria from developing new resistance mechanisms.

European Collaboration and Global Impact

As a leader in open innovation and networking, Biokeralty collaborates with a consortium of 16 organizations from 10 countries. This ambitious research is backed by the European Union’s Horizon Europe program, which has allocated approximately €6 million to the project.

Beyond the scientific breakthrough, the project aims to:

  • Save lives by providing new tools against resistant infections.
  • Reduce the economic burden on healthcare systems, currently estimated at billions of euros due to AMR.
  • Raise awareness among citizens and policymakers about the urgent need for sustainable solutions to tackle “superbugs".

This international visibility underscores Biokeralty’s commitment to sharing and generating knowledge that benefits both the Keralty community and society at large.

For those interested in reading the full reports from the Icelandic press, you can access them through the following links:

  • Morgunblaðið (mbl.is)
  • RÚV

 

Biokeralty takes part in the final meeting of the European Convert2Green project

Prev Post

TEN4CARE at TERMIS-EU 2026: Advancing the Conversation on Smart Biomaterials and Regulatory Innovation

Next Post
More news
IN-ARMOR Consortium Strategize for Upcoming Project Review and Clinical Transitions
by YIDOSA Websites 06/01/2026
SPRI highlights Biokeralty’s participation in OPADE, the European project applying artificial intelligence to the treatment of depression
by YIDOSA Websites 06/01/2026
TEN4CARE at TERMIS-EU 2026: Advancing the Conversation on Smart Biomaterials and Regulatory Innovation
by YIDOSA Websites 05/13/2026
Biokeralty takes part in the final meeting of the European Convert2Green project
by YIDOSA Websites 05/12/2026
The European IN-ARMOR project coordinates its upcoming milestones at the 12th meeting of its Management Board
by YIDOSA Websites 03/16/2026

Scientific resources

Patents and publications

For those people interested in the scientific publications and patents developed by the BioKeralty team, this section gathers detailed information and useful references corresponding to its scientific research.

Nanomaterials, biomedical applications, in vitro and in vivo antimicrobial activities, nanomedicine, fatty acids, nanofibrous membranes, tissue reparations, etc. constitute some of the research topics included in this section.

Awesome Image

  • C/Albert Einstein 25, Edificio E-3, 1ª planta Oficina 2

    Parque Tecnológico de Álava,

    01510 Miñano, Vitoria-Gasteiz (Álava), España

  • BioKeralty
  • Areas and lines of research
  • Projects
  • Resources
  • Legal
  • Privacy policy
  • Cookies policy
  • Contact

Copyright © BioKeralty 2023

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Logotipo BioKeralty
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Analytics

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Marketing

This website uses the following additional cookies:

(List the cookies that you are using on the website here.)